Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
An. bras. dermatol ; 92(5,supl.1): 34-36, 2017. graf
Article Dans Anglais | LILACS | ID: biblio-887060

Résumé

Abstract: Bullous pemphigoid is a blistering autoimmune disease characterized by two hemidesmosomal proteins (anti-BP180 and 230). Pemphigus, by contrast, is characterized by two autoantibodies (anti-desmoglein 1 and 3). Coexistence of autoantibodies of bullous pemphigoid and pemphigus in a patient is rare. A 25-year-old male patient was admitted to our hospital, reporting a 3-month history of multiple papules, vesicles, and erosions over an extensive erythema on the entire body. Laboratory tests showed high levels of serum IgE, anti-BP180 antibodies, and anti-desmoglein 1 and 3. Histopathologic and immunopathologic features were characterized by bullous pemphigoid. No improvement was seen with systemic corticosteroid therapy, however, pulse corticosteriod therapy combined with methylprednisolone, immunosuppressants, immunomodulators, and plasmapheresis led to the recovery of his condition with numerous milia.


Sujets)
Humains , Mâle , Adulte , Immunoglobuline E/sang , Pemphigoïde bulleuse/immunologie , Pemphigoïde bulleuse/anatomopathologie , Desmogléines/immunologie , Kératose/immunologie , Kératose/anatomopathologie , Peau/anatomopathologie , Autoanticorps/sang , Autoantigènes/sang , Biopsie , Méthylprednisolone/usage thérapeutique , Pemphigoïde bulleuse/traitement médicamenteux , Collagènes non fibrillaires/sang , Escarre/anatomopathologie , Glucocorticoïdes/usage thérapeutique , Kératose/traitement médicamenteux
SÉLECTION CITATIONS
Détails de la recherche